Not sure what clinical trials are? Clinical trials are carefully controlled research studies conducted by doctors to improve the care and treatment of patients. The goal of clinical trials is to develop therapies that are more effective against the disease with fewer adverse side effects. Treatments proven safe and effective in clinical trials are usually approved by the U.S. Food and Drug Administration (FDA) for use as a standard treatment.
Disclaimer: These resources are regularly reviewed to ensure that links still work correctly and the resources listed continue to be helpful to our visitors. If you find that a link isn't working or information is incorrect or if you'd like to have your own organization listed here, please email email@example.com. Because we want to be sure that our visitors find the most relevant resources, we encourage you to visit the organization's website for more detailed information.
American Cancer Fund (ACF)
Contact: 908 431-9800
Population served: Anyone affected by cancer and needing information
Mission: Dedicated to the education, support and empowerment of those diagnosed with cancer by organizing and clarifying information. Provides information about:
- Living with Cancer
- Clinical Trials
- Complementary and Alternative Medicine
- Nutrition and Exercise
- Oral Health
Contact: Website only
Population served: General public and health professionals interested in clinical trials primarily in the U.S.
Mission: CenterWatch is a source of clinical trials information for patients, caregivers and clinical research professionals.
Offers online tools to:
- Search clinical trials
- Receive email notifications about specific clinical trials
- Review results from completed clinical trials
- Search drug information
- Learn about volunteering for a clinical trial
- Learn about the informed consent process
- Read an overview of the clinical trials process
- Find disease-specific health associations and other educational resources
- Review definitions of commonly-used clinical research terms
Population served: People seeking information about clinical trials, worldwide
Mission: ClinicalTrials.gov is a web-based resource that provides patients, their family members, health professionals, researchers, and the public with easy access to information on publicly and privately supported clinical studies on a wide range of diseases and conditions. The website is maintained by the National Library of Medicine at the National Institutes of Health.
Each clinical trial record presents summary information about a study protocol and includes the following:
- Disease or condition
- Intervention (for example, the medical product, behavior, or procedure being studied)
- Title, description, and design of the study
- Requirements for participation (eligibility criteria)
- Locations where the study is being conducted
- Contact information for the study locations
Cord Blood Registry
Contact: 888.CORD.BLOOD or 888.932.6568
Population served: Patients, families, caregivers
Other language(s): Spanish and Chinese
Mission: To advance the clinical application of newborn stem cells by partnering with leading research institutions to establish FDA-regulated clinical trials, exclusive to CBR families, for conditions that have no cure today.
- Newborn Possibilities Program® offers free cord blood and tissue processing and five years of storage to qualifying families in the U.S.
- Genetic counselors are available to discuss your family's medical history and to answer questions about how newborn stem cells might be applicable to your family.
National Cancer Institute's Cancer Information Service
Population served: People with cancer and their caregivers in the U.S.
Other language(s): Spanish
Mission: To provide accurate, up-to-date, and reliable information on cancer that is easy to understand; this confidential service is a federally funded cancer education program.
- Offers trained information specialists who can answer cancer-related questions on a range of cancer topics, including the most recent advances in cancer treatment.
Mission: To provides financial assistance to young adult patients between 15 -39, battling cancer who are undergoing or actively pursuing clinical trial treatment options.
- Requests may be made for medical expenses, housing costs, travel expenses as well as food, clothing and utility bills.
St. Jude International Outreach Program
Population served: pediatric blood cancer patients, their caregivers, and healthcare providers specializing in pediatric catastrophic diseases worldwide
Mission: To improve the survival rates of children with catastrophic illnesses worldwide, through the transfer of knowledge, technology and organizational skills.
- Clinical trials designed to provide the best available care while answering important research questions.
- Program develops partnerships with medical institutions and fund-raising organizations to facilitate the involvement of other agencies and organizations to support key programs and the education of local personnel.
- Sharing knowledge and technology with the local governments, healthcare providers, and the private sector to increase the survival rates of children all across the globe.
- Pediatric specialty committed to caring for and supporting children with cancer regardless of the family's financial or healthcare resources.
- Hosts visiting fellows at its campus in Memphis, Tennessee.
- Partner sites in various countries. Please see the website for more details on locations.
The Double Hit Lymphoma Foundation
Population served: Anyone who has been affected by double hit lymphoma (diffuse large B cell lymphoma with MYC and BCL2 translocations)
Mission: To increase awareness of double hit lymphoma, provide information, tools and connections to make the cancer journey more manageable, and to raise funds for double hit lymphoma research.
- Provides information about clinical trials, treatment options, and healthcare providers
- Provides support with patient to patient connections program
- Partners with the Lymphoma Research Foundation for the Lymphoma Education and Advocacy Partners (LEAP) initiative